IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Saturn V Capital Management LP

Q4 2024 Holdings

Filed 2025-02-14 | 24 holdings | $255.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Disc Medicine Inc(IRON)COM254604101$32.3M509,40612.6%
Ascendis Pharma A/S(ASND)SPONSORED ADR04351P101$27.4M198,97710.7%
Moonlake Immunotherapeutics(MLTX)CLASS A ORD61559X104$18.7M346,1117.3%
CG Oncology Inc(CGON)COM156944100$17.0M593,2626.7%
Vaxcyte Inc(PCVX)COM92243G108$16.7M204,2856.5%
Cytokinetics Inc(CYTK)COM NEW23282W605$16.4M348,3646.4%
Cargo Therapeutics Inc(CRGX)COM14179K101$14.5M1,007,6775.7%
Celcuity Inc(CELC)COM15102K100$13.9M1,063,7835.5%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$13.1M988,5285.1%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$12.6M322,4705.0%
Argenx SE(ARGX)SPONSORED ADR04016X101$12.1M19,7544.8%
Cogent Biosciences Inc(COGT)COM19240Q201$11.7M1,498,4254.6%
Merus N VCOMN5749R100$9.9M234,6373.9%
Contineum Therapeutics Inc(CTNM)CL A21217B100$8.4M573,0223.3%
Abivax SA(ABVX)SPONSORED ADS00370M103$4.8M653,0711.9%
Kalvista Pharmaceuticals Inc(KALV)COM483497103$4.7M556,4891.8%
Inozyme Pharma IncCOM45790W108$3.8M1,374,5821.5%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$3.6M814,5331.4%
Amylyx Pharmaceuticals Inc(AMLX)COM03237H101$3.4M889,0731.3%
Crinetics Pharmaceuticals in(CRNX)COM22663K107$3.0M59,1251.2%
Silence Therapeutics PLC(SLN)ADS82686Q101$2.7M395,0241.1%
Newamsterdam Pharma Company(NAMS)ORDINARY SHARESN62509109$2.6M100,0001.0%
Ocular Therapeutix Inc(OCUL)COM67576A100$1.6M191,4560.6%
MBX Biosciences Inc(MBX)COM55287L101$331.7K18,0000.1%